Pediatric Anxiety Rating Scale/ Pediatric Anxiety Rating Scale-Revised |
Parent/Child Clinician-rated interview(30–45 min.) |
Riddle et al.,2002 |
128 children, ages 2002 6–17 years(DSM-IV diagnosis of SoP, SAD, or GAD) |
ICC = .97;α= .64; ICC = .55; r = .61 (CGI-S) |
Used with pediatric populations and with developmental disabilities; clinically-sensitive, wide-range of anxiety symptom coverage, continuous distribution of scores; originally intended to be an outcome measure; sensitive to psychopharmacological treatment of anxiety |
Not originally intended for populations with developmental disabilities; does not render sub-categorization of anxiety |
|
|
Storch et al.,2012 |
72 children, ages 7–17 years(diagnosis of autism, Asperger’s syndrome, or PDD-NOS & GAD,SAD, SA, or OCD) |
ICC = .86; α= .59; ICC = .83 |
|
|
Anxiety, Depression, and Mood Scale |
Caregiver-rated questionnaire (15 min.) |
Esbensen et al.,2003 |
265 subjects, ages 10–79 years of age (diagnosisof MR) |
ICC = .75–.83; α= .48 (Full scale); α= .37–.62(subscales);ICC = .81 (Full scale); ICC 5.72–.83 (subscales) |
Established data in FXS; validated against DSM-IV; normed and developed forintellectual disability |
Does not have anestablished track record, limited anxiety symptom coverage, not intended as outcome measure |
Anxiety Disorders Interview Schedule-IV |
Parent/Child Clinician-rated interview (1 hr.) |
Silverman, Saavedra,& Pina,2001 |
62 children, ages 7–16 years and their parents (exclusion criteria:developmental delays and severe psychopathology) |
ICC =.78–.96 (Symptom scales); κ = .80 to .92(Combined diagnoses of these disorders); κ = .63–.80 (child-only interview); κ = .65–.88(parent-only interview); r = .94(parent); r = .92(child) |
Used with pediatric populations and with developmental disabilities; used in assessment of DSM-IV anxiety disorders |
Assesses anxiety over the past year and therefore not an effective outcome measure; not a continuous measure of severity |
Aberrant Behavior Checklist-Community Edition |
Caregiver-rated questionnaire (15 min.) |
Aman et al.,1995 |
927 institutionalized, profoundly developmentally delayed adolescents and adults |
ICC −.86–.94; α = .96–.99 |
Used with pediatric populations and with developmental disabilities; used in many FXS clinical trials; offers ratings of behaviors that may be present when anxious(e.g., inappropriate speech); sensitive to treatment effects |
Does not have anxiety subscales; many symptoms not relevant for higher functioning patients without ID |
Child Behavior Checklist |
Caregiver-rated questionnaire (20 min.) |
Achenbach,1991 |
2,368 nationally-representative children, ages 4–18 years without disabilities |
ICC = .92–.96; α = .83–.92 |
Used with pediatric populations; provides broad-band internalizing and externalizing scores and narrow-band scaled scores |
Not generally used as outcome measure; many itemsinappropriate for developmental/ intellectual disability; not specifically normed in ID |
Clinical Global Impression-Severity Scale |
Clinical impression (10 min.) |
Forkman et al.,2011 |
31 inpatient adults with major depressive disorder |
ICC = .22–.24 |
Used with pediatric populations and developmental disabilities; used in controlled treatment studies |
No specific interviewer guide available so response format can be ambiguous |
Multidimensional Anxiety Questionnaire |
Self-report questionnaire (10 min.) |
Reynolds,1999 |
More than 1,800college students,600 community adults, 407 psychiatric outpatients diagnosed with anxiety-related or other disorders |
α = .96 (Total scale); α = .88 to .91(subscales); α = .95(Total scale); α =.90–.93 (subscales) |
Used with women with pre-mutation FXS; provides global assessment of DSM-IV anxiety symptoms in four domains; provides a cutoff score for clinically relevant anxiety; easy to administer/score screener; clinically valid |
Not used with pediatric populations; self-report may not be possible for some individuals with developmental disabilities; onlynormed for 18 and older |